Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 11-20 of 64 (Search time: 0.003 seconds).
previous
1
2
3
4
5
...
7
next
Item hits:
Preview
Issue Date
Title
Author(s)
2000
Normal and leukemic engraftment in the nod/scid mouse model
Hughes, T.
;
White, D.
;
Bresatz, S.
;
Forte, M.
;
Lewis, I.
;
Lyons, A.
2009
Dasatinib or high-dose Imatinib for chronic-phase chronic myeloid leukemia resistant to Imatinib at a dose of 400 to 600 milligrams daily. Two-year follow-up of a randomized phase 2 study (START-R)
Kantarjian, H.
;
Pasquini, R.
;
Levy, V.
;
Jootar, S.
;
Holowiecki, J.
;
Hamerschlak, N.
;
Hughes, T.
;
Bleickardt, E.
;
Dejardin, D.
;
Cortes, J.
;
Shah, N.
2000
Inappropriate antidiuretic hormone secretion, abdominal pain and disseminated varicella-zoster virus infection: an unusual triad in a patient 6 months post mini-allogeneic peripheral stem cell transplant for chronic myeloid leukemia
Szabo, F.
;
Horvath, N.
;
Seimon, S.
;
Hughes, T.
2007
Reliability of PCR for BCR-ABL transcripts
Hughes, T.
;
Branford, S.
;
Goldman, J.
2000
Engraftment of T-cell-depleted allogeneic haematopoietic stem cells using a reduced intensity conditioning regimen
Craddock, C.
;
Bardy, P.
;
Kreiter, S.
;
Johnston, R.
;
Apperley, J.
;
Marks, D.
;
Huber, C.
;
Kolbe, K.
;
Goulding, R.
;
Lawler, M.
;
Goldman, J.
;
Hughes, T.
;
Derigs, G.
2009
Dasatinib treatment for Philadelphia chromosome-positive Leukemias: practical considerations
Khoury, H.
;
Guilhot, F.
;
Hughes, T.
;
Kim, D.
;
Cortes, J.
2008
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia
le Coutre, P.
;
Ottmann, O.
;
Giles, F.
;
Kim, D.
;
Cortes, J.
;
Gattermann, N.
;
Apperley, J.
;
Larson, R.
;
Abruzzese, E.
;
O'Brien, S.
;
Kuliczkowski, K.
;
Hochhaus, A.
;
Mahon, F.
;
Saglio, G.
;
Gobbi, M.
;
Kwong, Y.
;
Baccarani, M.
;
Hughes, T.
;
Martinelli, G.
;
Radich, J.
;
et al.
2009
A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph plus CML or relapsed/refractory Ph plus ALL
Tojo, A.
;
Usuki, K.
;
Urabe, A.
;
Maeda, Y.
;
Kobayashi, Y.
;
Jinnai, I.
;
Ohyashiki, K.
;
Nishimura, M.
;
Kawaguchi, T.
;
Tanaka, H.
;
Miyamura, K.
;
Miyazaki, Y.
;
Hughes, T.
;
Branford, S.
;
Okamoto, S.
;
Ishikawa, J.
;
Okada, M.
;
Usui, N.
;
Tanii, H.
;
Amagasaki, T.
;
et al.
2009
Genomic translocation breakpoint sequences are conserved in BCR-ABL1 cell lines despite the presence of amplification
Ross, D.
;
Schafranek, L.
;
Hughes, T.
;
Nicola, M.
;
Branford, S.
;
Score, J.
2009
Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo
Fraser, C.
;
Blake, S.
;
Diener, K.
;
Lyons, A.
;
Brown, M.
;
Hughes, T.
;
Hayball, J.
Discover
Author
24
Branford, S.
15
Hochhaus, A.
10
Goldman, J.
9
Radich, J.
9
White, D.
8
Cortes, J.
8
Grigg, A.
7
Rudzki, Z.
6
Arthur, C.
6
Guilhot, F.
.
next >
Subject
40
Humans
27
Leukemia, Myelogenous, Chronic, B...
27
Pyrimidines
24
Benzamides
24
Imatinib Mesylate
24
Piperazines
20
Fusion Proteins, bcr-abl
16
Male
14
Adult
14
Antineoplastic Agents
.
next >
Date issued
16
2009
8
2008
5
2007
7
2006
4
2005
4
2004
9
2003
4
2002
2
2001
5
2000
.
next >